Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening 论文

摘要

inhibitors that may have potential for further clinical evaluation as part of drug combination therapies to treating COVID-19 patients and as starting points for chemistry optimization for new drug development.